PolyPeptide Group AG
SIX:PPGN.SW
Overview | Financials
Company Name | PolyPeptide Group AG |
Symbol | PPGN.SW |
Currency | CHF |
Price | 32.15 |
Market Cap | 1,060,423,287 |
Dividend Yield | 0% |
52-week-range | 14.11 - 35.8 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Juan Jose Gonzalez |
Website | https://www.polypeptide.com |
An error occurred while fetching data.
About PolyPeptide Group AG
PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products. It engages in manufacturing custom research grade peptides; and developing neoantigen peptide
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD